These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25409418)
1. Relationship between the brain natriuretic peptide (BNP) level and remission of diabetic nephropathy with microalbuminuria: a 3-year follow-up study. Seki N; Matsumoto T; Fukazawa M Horm Metab Res; 2015 Feb; 47(2):138-44. PubMed ID: 25409418 [TBL] [Abstract][Full Text] [Related]
2. Relationship Between the Brain Natriuretic Peptide (BNP) Level and Prognosis of Diabetic Nephropathy with Microalbuminuria: A 7-Year Follow-Up Study. Seki N; Matsumoto T; Fukazawa M Horm Metab Res; 2018 May; 50(5):389-396. PubMed ID: 29723897 [TBL] [Abstract][Full Text] [Related]
3. Relationship between BNP level and renal function in diabetic nephropathy with microalbuminuria. Seki N; Nishimura M; Matsumoto T; Fukazawa M; Kenmochi T J Diabetes Complications; 2013; 27(1):92-7. PubMed ID: 22885249 [TBL] [Abstract][Full Text] [Related]
4. B-type natriuretic peptide and renal function in Japanese patients with type 2 diabetes mellitus: The Dogo Study. Furukawa S; Sakai T; Niiya T; Miyaoka H; Miyake T; Yamamoto S; Tanaka K; Ueda T; Senba H; Torisu M; Minami H; Matsuura B; Hiasa Y; Miyake Y Endocr J; 2017 Dec; 64(12):1131-1136. PubMed ID: 28855437 [TBL] [Abstract][Full Text] [Related]
5. Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. Yano Y; Katsuki A; Gabazza EC; Ito K; Fujii M; Furuta M; Tuchihashi K; Goto H; Nakatani K; Hori Y; Sumida Y; Adachi Y J Clin Endocrinol Metab; 1999 Jul; 84(7):2353-6. PubMed ID: 10404802 [TBL] [Abstract][Full Text] [Related]
6. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Agardh CD; Agardh E; Torffvit O Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466 [TBL] [Abstract][Full Text] [Related]
7. Plasma brain natriuretic peptide levels in normotensive Type 2 diabetic patients without cardiac disease and macroalbuminuria. Asakawa H; Fukui T; Tokunaga K; Kawakami F J Diabetes Complications; 2002; 16(3):209-13. PubMed ID: 12015190 [TBL] [Abstract][Full Text] [Related]
8. Plasma B-type natriuretic peptide is useful for cardiovascular risk assessment in community-based diabetes subjects: comparison with albuminuria. Onodera M; Nakamura M; Tanaka F; Takahashi T; Makita S; Ishisone T; Ishibashi Y; Itai K; Onoda T; Ohsawa M; Tanno K; Sakata K; Omama S; Ogasawara K; Ogawa A; Kuribayashi T; Sakamaki K; Okayama A Int Heart J; 2012; 53(3):176-81. PubMed ID: 22790686 [TBL] [Abstract][Full Text] [Related]
9. Remission of diabetic nephropathy in type 2 diabetic Asian population: role of tight glucose and blood pressure control. Hsieh MC; Hsieh YT; Cho TJ; Chen JF; Lin SD; Chen HC; Tu ST Eur J Clin Invest; 2011 Aug; 41(8):870-8. PubMed ID: 21299554 [TBL] [Abstract][Full Text] [Related]
10. Brain natriuretic polypeptide in type 2 NIDDM patients with albuminuria. Nagai T; Imamura M; Inukai T; Mori M J Med; 2001; 32(3-4):169-80. PubMed ID: 11563815 [TBL] [Abstract][Full Text] [Related]
11. Serum uric acid is related to cardiovascular events and correlates with N-terminal pro-B-type natriuretic peptide and albuminuria in patients with diabetes mellitus. Resl M; Clodi M; Neuhold S; Kromoser H; Riedl M; Vila G; Prager R; Pacher R; Strunk G; Luger A; Hülsmann M Diabet Med; 2012 Jun; 29(6):721-5. PubMed ID: 22050532 [TBL] [Abstract][Full Text] [Related]
13. Association of circulating B-type natriuretic peptide with osteoporosis in a Chinese type 2 diabetic population. Chen P; Yan P; Wan Q; Zhang Z; Xu Y; Miao Y; Yang J BMC Musculoskelet Disord; 2021 Mar; 22(1):261. PubMed ID: 33691659 [TBL] [Abstract][Full Text] [Related]
14. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function. Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836 [TBL] [Abstract][Full Text] [Related]
15. Progression to overt nephropathy in type 2 diabetes: the Casale Monferrato Study. Bruno G; Merletti F; Biggeri A; Bargero G; Ferrero S; Pagano G; Cavallo Perin P; Diabetes Care; 2003 Jul; 26(7):2150-5. PubMed ID: 12832328 [TBL] [Abstract][Full Text] [Related]
16. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes. Saraheimo M; Forsblom C; Thorn L; Wadén J; Rosengård-Bärlund M; Heikkilä O; Hietala K; Gordin D; Frystyk J; Flyvbjerg A; Groop PH; Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990 [TBL] [Abstract][Full Text] [Related]
17. Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate. Kawasaki I; Hiura Y; Tamai A; Yoshida Y; Yakusiji Y; Ikuno Y; Okada M; Ueno H; Tanaka N; Yamagami K; Fukumoto M; Hosoi M J Diabetes; 2015 Jan; 7(1):41-6. PubMed ID: 24661437 [TBL] [Abstract][Full Text] [Related]
18. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria. Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385 [TBL] [Abstract][Full Text] [Related]
19. RISK FACTORS FOR DIABETIC NEPHROPATHY IN DIABETES MELLITUS TYPE 1. Mohammed MM; Alnajim EK; Hussein MAA; Hadi NR Wiad Lek; 2023; 76(1):145-154. PubMed ID: 36883503 [TBL] [Abstract][Full Text] [Related]
20. Effect of Home Blood Pressure on Inducing Remission/Regression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus. Nishimura M; Kato Y; Tanaka T; Taki H; Tone A; Yamada K; Suzuki S; Saito M; Ando Y; Hoshiyama Y Am J Hypertens; 2017 Aug; 30(8):830-839. PubMed ID: 28605498 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]